Edition:
India

Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

58.11USD
1:30am IST
Change (% chg)

$0.03 (+0.05%)
Prev Close
$58.08
Open
$58.02
Day's High
$60.15
Day's Low
$57.26
Volume
81,853
Avg. Vol
87,171
52-wk High
$85.66
52-wk Low
$50.26

Chart for

About

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The Company's product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka. Its... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $883.61
Shares Outstanding(Mil.): 15.17
Dividend: --
Yield (%): --

Financials

  EGRX.OQ Industry Sector
P/E (TTM): 9.78 30.90 33.64
EPS (TTM): 5.95 -- --
ROI: 64.07 14.75 14.27
ROE: 70.78 16.24 15.99

BRIEF-Eagle Pharmaceuticals Reports Q1 Adjusted Non-GAAP Earnings Per Share Of $0.53

* EAGLE PHARMACEUTICALS, INC. REPORTS FIRST QUARTER 2018 RESULTS

10 May 2018

BRIEF-Eagle Pharmaceuticals Says CEO Scott Tarriff's 2017 Total Compensation Was $8.04 Mln

* EAGLE PHARMACEUTICALS INC SAYS CEO SCOTT TARRIFF'S 2017 TOTAL COMPENSATION WAS $8.04 MILLION VERSUS $7.15 MILLION IN 2016 – SEC FILING Source : https://bit.ly/2HK04hV Further company coverage: (Reuters.Briefs@thomsonreuters.com)

01 May 2018

Earnings vs. Estimates